Mentaily Secures £3M Seed Funding to Revolutionise Psychiatric Care with AI

London, UK — Mental health technology startup Mentaily has announced a £3 million seed funding round to advance its AI-powered platform for psychiatric diagnosis and support. The investment will accelerate the development of its proprietary technology, which aims to transform early intervention in mental healthcare.

The funding was led by prominent venture capital firms, with participation from strategic angel investors in the healthtech sector. Mentaily’s innovative approach combines artificial intelligence with clinical expertise to provide faster, more accurate mental health assessments—a critical need as global demand for psychiatric services surges.

Bridging the Gap in Mental Healthcare

Traditional psychiatric diagnosis often involves lengthy waiting times and subjective assessments, leading to delays in treatment. Mentaily’s platform leverages machine learning to analyse patient data, including speech patterns, behavioural cues, and medical history, to assist clinicians in identifying conditions such as depression, anxiety, and bipolar disorder earlier and more precisely.

“Mental health diagnosis is still stuck in the past—reliant on outdated methods that haven’t evolved with technology,” said Dr. Elena Petrov, Mentaily’s co-founder and CEO. “Our AI doesn’t replace clinicians; it empowers them with data-driven insights to make better, faster decisions. This funding allows us to refine our algorithms and expand access to our tools.”

The Road Ahead

The fresh capital will be used to enhance Mentaily’s AI models, obtain regulatory approvals, and forge partnerships with healthcare providers. The company also plans to integrate its technology with electronic health record (EHR) systems, streamlining workflows for medical professionals.

Investors are betting on the startup’s potential to address systemic inefficiencies in mental healthcare. “Mentaily is at the forefront of a much-needed shift toward precision psychiatry,” noted Rajesh Gupta of Horizon Ventures, the round’s lead investor. “Their technology could significantly reduce misdiagnosis rates and improve outcomes for millions.”

With mental health disorders affecting one in four people globally, according to the World Health Organisation, scalable solutions like Mentaily’s could prove transformative. The company aims to pilot its platform with select UK clinics later this year before expanding internationally.

For further updates, visit www.mentaily.ai.